Clinical trial
A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea
NCT00196391 · Duramed Research, Industry · Completed
Key facts
| NCT number | NCT00196391 |
|---|---|
| Title | A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea |
| Official title | A Multicenter Study to Evaluate Induction of Withdrawal Bleeding After Administration of DR-2021 in Women With Secondary Amenorrhea |
| Lead sponsor | Duramed Research, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Amenorrhea |
| Intervention type | Drug, Other |
| Interventions | DR-2021a, DR-2021b, DR-2021c, DR-2021d, DR-2021e, Placebo |
| Enrollment | 180 |
| Start date | Sep 1, 2005 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Sep 20, 2005 |
| Last update posted | Jul 30, 2014 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: